Screener
Bioventus BVS U.S. Segment — Total Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Net sales | $153,208 | $147,660 | $285,297 | $271,536 |
| Cost of sales (including depreciation and amortization of $9,893, $10,603, $19,980 and $20,868, respectively) | 47,542 | 45,570 | 88,862 | 86,390 |
| Gross profit | 105,666 | 102,090 | 196,435 | 185,146 |
| Selling, general and administrative expense | 82,740 | 79,110 | 161,065 | 152,612 |
| Research and development expense | 3,173 | 3,172 | 5,640 | 6,183 |
| Restructuring costs | (415) | — | 39 | — |
| Depreciation and amortization | 1,041 | 1,439 | 2,148 | 3,032 |
| Loss on disposals | — | 1 | — | 82 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's U.S. segment — total net sales?
- Bioventus (BVS) reported U.S. segment — total net sales of $134.47M in Q2 2026.
- How has Bioventus's U.S. segment — total net sales changed year-over-year?
- Bioventus's U.S. segment — total net sales increased by 4.4% year-over-year, from $128.78M to $134.47M.
- What is the long-term trend for Bioventus's U.S. segment — total net sales?
- Over 3 years (2022 to 2025), Bioventus's U.S. segment — total net sales has grown at a 3.3% compound annual growth rate (CAGR), from $455.25M to $502.1M.
- What does U.S. segment — total net sales mean?
- This metric represents the total revenue generated from the sale of medical technology products and services within the United States market. It serves as a primary indicator of the company's commercial reach and market penetration in its largest geographic region.
Ask your AI about Bioventus's u.s. segment — total net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude